Meinian Health: The deviation value of the stock price has accumulated more than 20% for two consecutive days.

Meinian Health announced that the closing price of the company's stock deviated by more than 20% on both December 17 and 18, 2025, which is considered abnormal stock trading behavior. After self-examination, the company found no need to correct or supplement previous disclosures, and no undisclosed significant information that could affect stock prices through public media reports. The company's operations have been normal recently, with no significant changes in internal or external environments. There have been no undisclosed significant events related to the company or its controlling shareholders, and the controlling shareholders have not traded any company stocks during this period. The company reminds investors to be cautious of risks.